$SONO
Sonos Inc

2023 Q4 Form 10-K Financial Statement

#000095017023065135 Filed on November 20, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3 2023
Revenue $612.9M $373.4M $1.655B
YoY Change 93.77% 0.42% -5.54%
Cost Of Revenue $330.2M $201.6M $938.8M
YoY Change 71.8% 2.89% -1.8%
Gross Profit $282.7M $171.8M $716.5M
YoY Change 127.79% -2.32% -10.03%
Gross Profit Margin 46.12% 46.0% 43.29%
Selling, General & Admin $123.7M $115.3M $436.0M
YoY Change 5.87% 8.37% -3.27%
% of Gross Profit 43.78% 67.11% 60.86%
Research & Development $79.24M $77.76M $301.0M
YoY Change 17.78% 24.37% 17.54%
% of Gross Profit 28.03% 45.27% 42.01%
Depreciation & Amortization $11.88M $12.21M $48.97M
YoY Change 9.93% 37.07% 27.18%
% of Gross Profit 4.2% 7.11% 6.83%
Operating Expenses $203.0M $193.0M $737.0M
YoY Change 10.22% 14.29% 4.27%
Operating Profit $79.70M -$21.26M -$20.55M
YoY Change -232.68% -405.47% -122.95%
Interest Expense $105.0K $274.0K $733.0K
YoY Change -88.36% 39.8% -33.54%
% of Operating Profit 0.13%
Other Income/Expense, Net $13.24M $3.541M $24.94M
YoY Change -258.35% -136.79% -213.86%
Pretax Income $92.94M -$17.72M $4.394M
YoY Change -237.63% 564.92% -93.61%
Income Tax $12.00M $5.900M $14.67M
% Of Pretax Income 12.91% 333.82%
Net Earnings $80.95M -$23.57M -$10.27M
YoY Change -226.35% 3848.24% -115.25%
Net Earnings / Revenue 13.21% -6.31% -0.62%
Basic Earnings Per Share $0.65 -$0.18 -$0.08
Diluted Earnings Per Share $0.64 -$0.18 -$0.08
COMMON SHARES
Basic Shares Outstanding 125.2M 128.3M 127.7M
Diluted Shares Outstanding 126.7M 128.3M 127.7M

Balance Sheet

Concept 2023 Q4 2023 Q3 2023
SHORT-TERM ASSETS
Cash & Short-Term Investments $467.3M $268.3M $220.2M
YoY Change 70.03% -38.99% -19.87%
Cash & Equivalents $467.3M $268.3M $220.2M
Short-Term Investments
Other Short-Term Assets $37.69M $27.00M $25.30M
YoY Change 1.75% 16.74% -31.71%
Inventory $173.0M $298.1M $346.5M
Prepaid Expenses
Receivables $80.81M $114.7M $67.58M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $758.9M $708.1M $659.6M
YoY Change -12.51% -23.32% -23.95%
LONG-TERM ASSETS
Property, Plant & Equipment $86.82M $94.15M $136.0M
YoY Change -24.18% 24.11% 18.77%
Goodwill $82.29M $81.78M
YoY Change 6.45% 2.45%
Intangibles $91.59M $93.74M
YoY Change 0.58% -3.3%
Long-Term Investments
YoY Change
Other Assets $34.84M $34.99M $36.19M
YoY Change -8.65% -6.06% -5.11%
Total Long-Term Assets $351.1M $357.1M $342.6M
YoY Change 9.38% 11.69% 6.73%
TOTAL ASSETS
Total Short-Term Assets $758.9M $708.1M $659.6M
Total Long-Term Assets $351.1M $357.1M $342.6M
Total Assets $1.110B $1.065B $1.002B
YoY Change -6.6% -14.32% -15.66%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $176.4M $148.9M $188.0M
YoY Change -47.47% -51.66% -44.01%
Accrued Expenses $97.99M $91.91M $109.0M
YoY Change -26.27% -14.89% -17.99%
Deferred Revenue $20.94M $20.03M
YoY Change -23.34% 9.24%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $376.0M $344.5M $354.2M
YoY Change -29.8% -31.81% -33.87%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $3.804M $2.940M $119.5M
YoY Change -95.39% 234.09% 44.71%
Total Long-Term Liabilities $3.804M $2.940M $119.5M
YoY Change -95.39% 234.09% 44.71%
TOTAL LIABILITIES
Total Short-Term Liabilities $376.0M $344.5M $354.2M
Total Long-Term Liabilities $3.804M $2.940M $119.5M
Total Liabilities $515.6M $475.0M $483.6M
YoY Change -17.88% -20.9% -22.98%
SHAREHOLDERS EQUITY
Retained Earnings $68.16M $18.45M
YoY Change -2811.18% -70.02%
Common Stock $127.0K $130.0K
YoY Change -2.31% -0.76%
Preferred Stock
YoY Change
Treasury Stock (at cost) $38.86M $32.35M
YoY Change -23.66% -50.27%
Treasury Stock Shares
Shareholders Equity $594.4M $590.2M $518.7M
YoY Change
Total Liabilities & Shareholders Equity $1.110B $1.065B $1.002B
YoY Change -6.6% -14.32% -15.66%

Cashflow Statement

Concept 2023 Q4 2023 Q3 2023
OPERATING ACTIVITIES
Net Income $80.95M -$23.57M -$10.27M
YoY Change -226.35% 3848.24% -115.25%
Depreciation, Depletion And Amortization $11.88M $12.21M $48.97M
YoY Change 9.93% 37.07% 27.18%
Cash From Operating Activities $275.4M $8.887M $100.4M
YoY Change -365.02% -232.31% -455.29%
INVESTING ACTIVITIES
Capital Expenditures $6.077M $16.68M $50.29M
YoY Change -128.57% -279.74% -208.81%
Acquisitions $0.00
YoY Change -100.0%
Other Investing Activities $0.00 $0.00
YoY Change -100.0% -100.0%
Cash From Investing Activities -$6.077M -$16.68M -$50.29M
YoY Change -71.43% -84.64% -70.87%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $100.1M
YoY Change -167.01%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -23.69M -18.27M -108.6M
YoY Change -34.34% -59.78% -27.73%
NET CHANGE
Cash From Operating Activities 275.4M 8.887M 100.4M
Cash From Investing Activities -6.077M -16.68M -50.29M
Cash From Financing Activities -23.69M -18.27M -108.6M
Net Change In Cash 247.1M -26.06M -54.62M
YoY Change -253.23% -83.79% -84.44%
FREE CASH FLOW
Cash From Operating Activities $275.4M $8.887M $100.4M
Capital Expenditures $6.077M $16.68M $50.29M
Free Cash Flow $269.3M -$7.795M $50.12M
YoY Change -425.87% -404.02% 179.13%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023 dei Entity Central Index Key
EntityCentralIndexKey
0001314727
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--09-30
CY2023 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2023 dei Amendment Flag
AmendmentFlag
false
CY2023Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q3 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P4Y
CY2023Q3 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P2Y
CY2023Q3 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P3Y
CY2023Q3 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2023Q3 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P5Y
CY2023Q3 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#OtherLiabilitiesCurrent
CY2022Q4 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#OtherLiabilitiesCurrent
CY2023Q3 us-gaap Lease Expiration Date1
LeaseExpirationDate1
2031-05-31
CY2023Q2 us-gaap Restructuring Reserve
RestructuringReserve
CY2023 dei Document Type
DocumentType
10-K
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2023 dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
CY2023 dei Document Transition Report
DocumentTransitionReport
false
CY2023 dei Entity File Number
EntityFileNumber
001-38603
CY2023 dei Entity Registrant Name
EntityRegistrantName
SONOS, INC.
CY2023 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
03-0479476
CY2023 dei Entity Address Address Line1
EntityAddressAddressLine1
614 Chapala Street
CY2023 dei Entity Address City Or Town
EntityAddressCityOrTown
Santa Barbara
CY2023 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2023 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
93101
CY2023 dei City Area Code
CityAreaCode
805
CY2023 dei Local Phone Number
LocalPhoneNumber
965-3001
CY2023 dei Security12b Title
Security12bTitle
Common Stock, $0.001 par value
CY2023 dei Trading Symbol
TradingSymbol
SONO
CY2023 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2023 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2023 dei Entity Small Business
EntitySmallBusiness
false
CY2023 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
true
CY2023 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2023 dei Entity Shell Company
EntityShellCompany
false
CY2023Q1 dei Entity Public Float
EntityPublicFloat
1546100000
CY2023Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
125150415
CY2023 dei Auditor Firm
AuditorFirmId
238
CY2023 dei Auditor Name
AuditorName
PricewaterhouseCoopers LLP
CY2023 dei Auditor Location
AuditorLocation
Los Angeles, California
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
220231000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
274855000
CY2023Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
31786000
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
26317000
CY2023Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
67583000
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
101206000
CY2023Q3 us-gaap Inventory Net
InventoryNet
346521000
CY2022Q4 us-gaap Inventory Net
InventoryNet
454288000
CY2023Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
25296000
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
37042000
CY2023Q3 us-gaap Assets Current
AssetsCurrent
659631000
CY2022Q4 us-gaap Assets Current
AssetsCurrent
867391000
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
87075000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
86168000
CY2023Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
48918000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
28329000
CY2023Q3 us-gaap Goodwill
Goodwill
80420000
CY2022Q4 us-gaap Goodwill
Goodwill
77300000
CY2023Q3 sono Indefinite Lived Intangible Assets Excluding Goodwill Net
IndefiniteLivedIntangibleAssetsExcludingGoodwillNet
69791000
CY2022Q4 sono Indefinite Lived Intangible Assets Excluding Goodwill Net
IndefiniteLivedIntangibleAssetsExcludingGoodwillNet
64680000
CY2023Q3 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
20218000
CY2022Q4 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
26384000
CY2023Q3 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
1659000
CY2022Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
1508000
CY2023Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
34529000
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
36628000
CY2023Q3 us-gaap Assets
Assets
1002241000
CY2022Q4 us-gaap Assets
Assets
1188388000
CY2023Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
187981000
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
335758000
CY2023Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
89717000
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
109290000
CY2023Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
22079000
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
23624000
CY2023Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
20188000
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
27318000
CY2023Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
34253000
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
39649000
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
354218000
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
535639000
CY2023Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
54956000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
25596000
CY2023Q3 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
60650000
CY2022Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
56152000
CY2023Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
9846000
CY2022Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
9642000
CY2023Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
3914000
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
846000
CY2023Q3 us-gaap Liabilities
Liabilities
483584000
CY2022Q4 us-gaap Liabilities
Liabilities
627875000
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
130399940
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
129823663
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
125113916
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
126668723
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
130000
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
130000
CY2023Q3 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
5286024
CY2022Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
3154940
CY2023Q3 us-gaap Treasury Stock Value
TreasuryStockValue
72586000
CY2022Q4 us-gaap Treasury Stock Value
TreasuryStockValue
50896000
CY2023Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
607345000
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
617390000
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-12788000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2514000
CY2023Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-3444000
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-3597000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
518657000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
560513000
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1002241000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1188388000
CY2023 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1655255000
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1752336000
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1716744000
CY2023 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
938765000
CY2022 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
955969000
CY2021 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
906750000
CY2023 us-gaap Gross Profit
GrossProfit
716490000
CY2022 us-gaap Gross Profit
GrossProfit
796367000
CY2021 us-gaap Gross Profit
GrossProfit
809994000
CY2023 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
301001000
CY2022 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
256073000
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
230078000
CY2023 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
267518000
CY2022 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
280333000
CY2021 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
272124000
CY2023 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
168518000
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
170429000
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
152828000
CY2023 us-gaap Operating Expenses
OperatingExpenses
737037000
CY2022 us-gaap Operating Expenses
OperatingExpenses
706835000
CY2021 us-gaap Operating Expenses
OperatingExpenses
655030000
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
-20547000
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
89532000
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
154964000
CY2023 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
10201000
CY2022 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
1655000
CY2021 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
146000
CY2023 us-gaap Interest Expense
InterestExpense
733000
CY2022 us-gaap Interest Expense
InterestExpense
552000
CY2021 us-gaap Interest Expense
InterestExpense
592000
CY2023 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
15473000
CY2022 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-21905000
CY2021 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2407000
CY2023 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
24941000
CY2022 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-20802000
CY2021 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1961000
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
4394000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
68730000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
156925000
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
14668000
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1347000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1670000
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-10274000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
67383000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
158595000
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-10274000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
67383000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
158595000
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.08
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.53
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.3
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.08
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.49
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.13
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
127702885
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
127691030
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
122245212
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
127702885
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
137762078
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
140309152
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-10274000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
67383000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
158595000
CY2023 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
153000
CY2022 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-2221000
CY2021 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
514000
CY2023 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-10121000
CY2022 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
65162000
CY2021 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
159109000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
297839000
CY2021 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
147818000
CY2021 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
50014000
CY2021 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
47837000
CY2021 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
62127000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
158595000
CY2021 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
514000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
569042000
CY2022 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
40443000
CY2022 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
150121000
CY2022 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
39653000
CY2022 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
75640000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
67383000
CY2022 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-2221000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
560513000
CY2023 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
21346000
CY2023 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
100064000
CY2023 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
29874000
CY2023 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
76857000
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-10274000
CY2023 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
153000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
518657000
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-10274000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
67383000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
158595000
CY2023 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
48969000
CY2022 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
38504000
CY2021 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
33882000
CY2023 us-gaap Restructuring Settlement And Impairment Provisions
RestructuringSettlementAndImpairmentProvisions
5533000
CY2023 us-gaap Share Based Compensation
ShareBasedCompensation
76857000
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
75640000
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
62127000
CY2023 sono Provision For Inventory Obsolescence
ProvisionForInventoryObsolescence
20640000
CY2022 sono Provision For Inventory Obsolescence
ProvisionForInventoryObsolescence
6276000
CY2021 sono Provision For Inventory Obsolescence
ProvisionForInventoryObsolescence
2790000
CY2023 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
5535000
CY2022 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
4705000
CY2021 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
2713000
CY2023 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-583000
CY2022 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-1508000
CY2021 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-8330000
CY2023 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
7335000
CY2022 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-10775000
CY2021 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
1108000
CY2023 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-32120000
CY2022 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
5513000
CY2021 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
45697000
CY2023 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-87004000
CY2022 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
277489000
CY2021 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
7911000
CY2023 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-10470000
CY2022 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
16604000
CY2021 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
30009000
CY2023 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-162345000
CY2022 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
129686000
CY2021 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
26231000
CY2023 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-2185000
CY2022 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-52904000
CY2021 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
33447000
CY2023 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-4576000
CY2022 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-1667000
CY2021 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
27587000
CY2023 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
576000
CY2022 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-5544000
CY2021 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-1091000
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
100406000
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-28260000
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
253226000
CY2023 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
50286000
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
46216000
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
45531000
CY2022 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
126416000
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-50286000
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-172632000
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-45531000
CY2022 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
929000
CY2023 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
21346000
CY2022 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
40443000
CY2021 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
147818000
CY2023 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
100064000
CY2022 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
150121000
CY2021 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
50014000
CY2023 us-gaap Restricted Stock Value Shares Issued Net Of Tax Withholdings
RestrictedStockValueSharesIssuedNetOfTaxWithholdings
29874000
CY2022 us-gaap Restricted Stock Value Shares Issued Net Of Tax Withholdings
RestrictedStockValueSharesIssuedNetOfTaxWithholdings
39653000
CY2021 us-gaap Restricted Stock Value Shares Issued Net Of Tax Withholdings
RestrictedStockValueSharesIssuedNetOfTaxWithholdings
47837000
CY2021 us-gaap Repayments Of Debt
RepaymentsOfDebt
25000000
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-108592000
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-150260000
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
24967000
CY2023 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3848000
CY2022 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-14094000
CY2021 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
148000
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-54624000
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-365246000
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
232810000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
274855000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
640101000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
407291000
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
220231000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
274855000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
640101000
CY2023 us-gaap Interest Paid Net
InterestPaidNet
1330000
CY2022 us-gaap Interest Paid Net
InterestPaidNet
344000
CY2021 us-gaap Interest Paid Net
InterestPaidNet
502000
CY2023 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
9522000
CY2022 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
9306000
CY2021 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
4114000
CY2023 sono Lease Liabilities Paid Net
LeaseLiabilitiesPaidNet
14218000
CY2022 sono Lease Liabilities Paid Net
LeaseLiabilitiesPaidNet
14636000
CY2021 sono Lease Liabilities Paid Net
LeaseLiabilitiesPaidNet
18657000
CY2023 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
2784000
CY2022 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
9112000
CY2021 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
5653000
CY2023 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
31692000
CY2022 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
5054000
CY2021 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
2010000
CY2023 us-gaap Settlement Of Asset Retirement Obligations Through Noncash Payments Amount
SettlementOfAssetRetirementObligationsThroughNoncashPaymentsAmount
2290000
CY2023 us-gaap Property Plant And Equipment Disposals
PropertyPlantAndEquipmentDisposals
21300000
CY2022 us-gaap Property Plant And Equipment Disposals
PropertyPlantAndEquipmentDisposals
18900000
CY2021 us-gaap Property Plant And Equipment Disposals
PropertyPlantAndEquipmentDisposals
32900000
CY2023Q3 sono Numberof Countries Where Products Distributed
NumberofCountriesWhereProductsDistributed
60
CY2023 us-gaap Use Of Estimates
UseOfEstimates
<p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Use of Estimates and Judgments</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and judgments that affect the amounts reported and disclosed in the consolidated financial statements and accompanying notes. Actual results could differ materially from those estimates. For revenue recognition, examples of estimates and judgments include: determining the nature and timing of satisfaction of performance obligations, determining the standalone selling price ("SSP") of performance obligations and estimating variable consideration such as sales incentives and product returns. Additionally, estimates and judgments are made by management for allowances for credit losses, excess and obsolete inventory, loss on purchase commitments, useful lives associated with property and equipment, incremental borrowing rates associated with leases, the recording of and release of valuation allowances with respect to deferred tax assets and uncertain tax positions, impairment of long-lived assets, impairment of goodwill and indefinite-lived intangible assets, warranty, contingencies and valuation and assumptions underlying stock-based compensation and other equity instruments. On an ongoing basis, the Company evaluates its estimates and judgments compared to historical experience and trends that form the basis for making estimates and judgments about the carrying value of assets and liabilities.</span></p>
CY2023 us-gaap Accumulated Depreciation Depletion And Amortization Sale Of Property Plant And Equipment1
AccumulatedDepreciationDepletionAndAmortizationSaleOfPropertyPlantAndEquipment1
21100000
CY2022 us-gaap Accumulated Depreciation Depletion And Amortization Sale Of Property Plant And Equipment1
AccumulatedDepreciationDepletionAndAmortizationSaleOfPropertyPlantAndEquipment1
18800000
CY2023 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Concentration of Credit Risk</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Financial instruments that potentially subject the Company to significant concentrations of credit risk consist principally of cash and cash equivalents and accounts receivable. The Company maintains cash and cash equivalents in several high-quality financial institutions. Cash and cash equivalents held at these banks, including those held in foreign branches of global banks, may exceed the amount of insurance provided on such deposits. These deposits may be redeemed upon demand, and management believes that the financial institutions that hold the Company’s cash and cash equivalents are financially sound and, accordingly, minimal credit risk exists with respect to cash. The Company has not experienced any losses in such accounts.</span></p>
CY2023 sono Gain Loss In Relation To Purchase Commitments
GainLossInRelationToPurchaseCommitments
-14700000
CY2022 sono Gain Loss In Relation To Purchase Commitments
GainLossInRelationToPurchaseCommitments
-12000000
CY2023Q3 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
18000000
CY2022Q4 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
21700000
CY2023 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
3700000
CY2022 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1900000
CY2023Q3 us-gaap Capitalized Contract Cost Accumulated Amortization
CapitalizedContractCostAccumulatedAmortization
6200000
CY2022Q4 us-gaap Capitalized Contract Cost Accumulated Amortization
CapitalizedContractCostAccumulatedAmortization
2500000
CY2023 us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
0
CY2022 us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
0
CY2021 us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
0
CY2023 sono Product Warranty Period
ProductWarrantyPeriod
P1Y
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
1547000
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
1307000
CY2023 us-gaap Allowance For Doubtful Accounts Receivable Period Increase Decrease
AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease
1561000
CY2022 us-gaap Allowance For Doubtful Accounts Receivable Period Increase Decrease
AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease
2098000
CY2021 us-gaap Allowance For Doubtful Accounts Receivable Period Increase Decrease
AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease
1529000
CY2023 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
1594000
CY2023 us-gaap Multiemployer Plan Employer Contribution Cost
MultiemployerPlanEmployerContributionCost
9500000
CY2022 us-gaap Multiemployer Plan Employer Contribution Cost
MultiemployerPlanEmployerContributionCost
8200000
CY2021 us-gaap Multiemployer Plan Employer Contribution Cost
MultiemployerPlanEmployerContributionCost
7600000
CY2023 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2022 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
901000
CY2021 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
1289000
CY2023Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
2711000
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
2744000
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
1547000
CY2023Q3 us-gaap Lessee Operating Lease Renewal Term
LesseeOperatingLeaseRenewalTerm
P5Y
CY2023 sono Lessee Operating Lease Termination Period
LesseeOperatingLeaseTerminationPeriod
P1Y
CY2023 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1655255000
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1752336000
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1716744000
CY2023 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1655255000
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1752336000
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1716744000
CY2023 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1655255000
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1752336000
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1716744000
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
87075000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
86168000
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
2744000
CY2022Q4 sono Allowance For Sales Incentives
AllowanceForSalesIncentives
23573000
CY2021Q4 sono Allowance For Sales Incentives
AllowanceForSalesIncentives
19160000
CY2020Q4 sono Allowance For Sales Incentives
AllowanceForSalesIncentives
17515000
CY2023 sono Allowancefor Sales Incentives Chargeto Revenue
AllowanceforSalesIncentivesChargetoRevenue
139657000
CY2022 sono Allowancefor Sales Incentives Chargeto Revenue
AllowanceforSalesIncentivesChargetoRevenue
51225000
CY2021 sono Allowancefor Sales Incentives Chargeto Revenue
AllowanceforSalesIncentivesChargetoRevenue
95249000
CY2023 sono Allowancefor Sales Incentives Utilizationof Sales Incentives Allowance
AllowanceforSalesIncentivesUtilizationofSalesIncentivesAllowance
134155000
CY2022 sono Allowancefor Sales Incentives Utilizationof Sales Incentives Allowance
AllowanceforSalesIncentivesUtilizationofSalesIncentivesAllowance
46812000
CY2021 sono Allowancefor Sales Incentives Utilizationof Sales Incentives Allowance
AllowanceforSalesIncentivesUtilizationofSalesIncentivesAllowance
93604000
CY2023Q3 sono Allowance For Sales Incentives
AllowanceForSalesIncentives
29075000
CY2022Q4 sono Allowance For Sales Incentives
AllowanceForSalesIncentives
23573000
CY2021Q4 sono Allowance For Sales Incentives
AllowanceForSalesIncentives
19160000
CY2023Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
281571000
CY2022Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
406657000
CY2023Q3 us-gaap Inventory Parts And Components Net Of Reserves
InventoryPartsAndComponentsNetOfReserves
64950000
CY2022Q4 us-gaap Inventory Parts And Components Net Of Reserves
InventoryPartsAndComponentsNetOfReserves
47631000
CY2023Q3 us-gaap Inventory Net
InventoryNet
346521000
CY2022Q4 us-gaap Inventory Net
InventoryNet
454288000
CY2023 us-gaap Inventory Write Down
InventoryWriteDown
29700000
CY2022 us-gaap Inventory Write Down
InventoryWriteDown
8800000
CY2023Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
279762000
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
256389000
CY2023Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
192687000
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
170221000
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
87075000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
86168000
CY2023 us-gaap Depreciation
Depreciation
42700000
CY2022 us-gaap Depreciation
Depreciation
33300000
CY2021 us-gaap Depreciation
Depreciation
31800000
CY2021 us-gaap Accumulated Depreciation Depletion And Amortization Sale Of Property Plant And Equipment1
AccumulatedDepreciationDepletionAndAmortizationSaleOfPropertyPlantAndEquipment1
32200000
CY2022Q4 us-gaap Goodwill
Goodwill
77300000
CY2023 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
3120000
CY2023Q3 us-gaap Goodwill
Goodwill
80420000
CY2023Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
31931000
CY2023Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
11701000
CY2023Q3 sono Finite Lived Intangible Assets Gross Excluding Goodwill Impact
FiniteLivedIntangibleAssetsGrossExcludingGoodwillImpact
-12000
CY2023Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
20218000
CY2023 us-gaap Acquired Finite Lived Intangible Assets Weighted Average Useful Life
AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
P4Y10M17D
CY2023Q3 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
103690000
CY2023Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
11701000
CY2023Q3 sono Indefinite Lived Intangible Assets Excluding Goodwill Impact
IndefiniteLivedIntangibleAssetsExcludingGoodwillImpact
-1980000
CY2023Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
90009000
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
5969000
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
3367000
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
3038000
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
3022000
CY2023Q3 sono Finite Lived Intangible Asset Expected Amortization After Year Four
FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour
4822000
CY2023Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
20218000
CY2023Q3 sono Accrued Inventory And Supply Chain Costs
AccruedInventoryAndSupplyChainCosts
48384000
CY2022Q4 sono Accrued Inventory And Supply Chain Costs
AccruedInventoryAndSupplyChainCosts
51011000
CY2023Q3 sono Accrued Advertisingand Marketing Current
AccruedAdvertisingandMarketingCurrent
13029000
CY2022Q4 sono Accrued Advertisingand Marketing Current
AccruedAdvertisingandMarketingCurrent
21292000
CY2023Q3 us-gaap Taxes Payable Current
TaxesPayableCurrent
11410000
CY2022Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
7081000
CY2023Q3 sono Accrued Generaland Administrative
AccruedGeneralandAdministrative
9924000
CY2022Q4 sono Accrued Generaland Administrative
AccruedGeneralandAdministrative
21634000
CY2023Q3 sono Accrued Product Development Current
AccruedProductDevelopmentCurrent
4298000
CY2022Q4 sono Accrued Product Development Current
AccruedProductDevelopmentCurrent
8168000
CY2023Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
2672000
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
104000
CY2023Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
89717000
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
109290000
CY2023 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
80000000
CY2022 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
73800000
CY2022Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
83470000
CY2021Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
89498000
CY2020Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
62389000
CY2023 sono Contract With Customer Liability Recognition Of Period Deferred Revenue
ContractWithCustomerLiabilityRecognitionOfPeriodDeferredRevenue
27057000
CY2022 sono Contract With Customer Liability Recognition Of Period Deferred Revenue
ContractWithCustomerLiabilityRecognitionOfPeriodDeferredRevenue
41438000
CY2021 sono Contract With Customer Liability Recognition Of Period Deferred Revenue
ContractWithCustomerLiabilityRecognitionOfPeriodDeferredRevenue
19175000
CY2023 sono Contract With Customer Liability Revenue Deferred Netof Revenue Recognized On Contracts
ContractWithCustomerLiabilityRevenueDeferredNetofRevenueRecognizedOnContracts
24425000
CY2022 sono Contract With Customer Liability Revenue Deferred Netof Revenue Recognized On Contracts
ContractWithCustomerLiabilityRevenueDeferredNetofRevenueRecognizedOnContracts
35410000
CY2021 sono Contract With Customer Liability Revenue Deferred Netof Revenue Recognized On Contracts
ContractWithCustomerLiabilityRevenueDeferredNetofRevenueRecognizedOnContracts
46284000
CY2023Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
80838000
CY2022Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
83470000
CY2021Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
89498000
CY2023Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
20188000
CY2023Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
17086000
CY2023Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
14718000
CY2023Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
12088000
CY2023Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
16758000
CY2023Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
80838000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
30115000
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
4394000
CY2023Q3 sono Accrued Liabilities Reserve For Returns
AccruedLiabilitiesReserveForReturns
21462000
CY2022Q4 sono Accrued Liabilities Reserve For Returns
AccruedLiabilitiesReserveForReturns
18263000
CY2023Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1153000
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
10532000
CY2023Q3 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
7466000
CY2022Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
5771000
CY2023Q3 us-gaap Other Sundry Liabilities Current
OtherSundryLiabilitiesCurrent
4172000
CY2022Q4 us-gaap Other Sundry Liabilities Current
OtherSundryLiabilitiesCurrent
5083000
CY2023Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
34253000
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
39649000
CY2022Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
5771000
CY2021Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
5604000
CY2023 us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
12517000
CY2022 us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
13033000
CY2023 us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
10822000
CY2022 us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
12866000
CY2023Q3 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
7466000
CY2022Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
5771000
CY2023Q3 us-gaap Lessee Operating Lease Renewal Term
LesseeOperatingLeaseRenewalTerm
P5Y
CY2023 sono Lessee Operating Lease Termination Period
LesseeOperatingLeaseTerminationPeriod
P1Y
CY2023Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0514
CY2023Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P9Y1M6D
CY2023Q3 us-gaap Land Subject To Ground Leases
LandSubjectToGroundLeases
50000
CY2023 us-gaap Lessee Operating Lease Option To Extend
LesseeOperatingLeaseOptionToExtend
The lease expires in May 2031, with no option to extend
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
68730000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
156925000
CY2023 us-gaap Operating Lease Cost
OperatingLeaseCost
12324000
CY2023 us-gaap Short Term Lease Cost
ShortTermLeaseCost
340000
CY2023 us-gaap Variable Lease Cost
VariableLeaseCost
5480000
CY2023 us-gaap Lease Cost
LeaseCost
18144000
CY2023 us-gaap Operating Lease Expense
OperatingLeaseExpense
12700000
CY2022 us-gaap Operating Lease Expense
OperatingLeaseExpense
11300000
CY2023 sono Operating Lease Maintenance Expense
OperatingLeaseMaintenanceExpense
5500000
CY2022 sono Operating Lease Maintenance Expense
OperatingLeaseMaintenanceExpense
4300000
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
4415000
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
9579000
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
7888000
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
6395000
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
5841000
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
41040000
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
75158000
CY2023Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
19049000
CY2023Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
56109000
CY2022Q4 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
100000000
CY2023 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
6555702
CY2023 us-gaap Treasury Stock Value Acquired Par Value Method
TreasuryStockValueAcquiredParValueMethod
100000000
CY2023 us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
15.25
CY2023 us-gaap Treasury Stock Shares Retired
TreasuryStockSharesRetired
6138129
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
10802882
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
13.37
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y6M
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
10956000
CY2023 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
2005776
CY2023 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
10.64
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
247149
CY2023 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
14.2
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
8549957
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
13.99
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P3Y7M6D
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
1689000
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
8549957
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
13.99
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P3Y7M6D
CY2023Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
1689000
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
8549957
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
13.99
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P3Y7M6D
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
1689000
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
2600000
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
6600000
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
10800000
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
15300000
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
58000000
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
242700000
CY2023 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
7507000
CY2023 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
4947000
CY2022 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
483000
CY2021 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
440000
CY2023 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
76857000
CY2022 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
75640000
CY2021 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
62127000
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-9904000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
54609000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
126810000
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
14298000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
14121000
CY2023 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
2810000
CY2022 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
3401000
CY2021 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
6216000
CY2023 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
15264000
CY2022 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
3884000
CY2021 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
6656000
CY2022 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-1459000
CY2022 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-21000
CY2023 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
-596000
CY2022 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
-1057000
CY2021 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
-8326000
CY2023 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-596000
CY2022 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-2537000
CY2021 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-8326000
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
14668000
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1347000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1670000
CY2023Q3 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
75593000
CY2022Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
92487000
CY2023Q3 sono Deferred Tax Assets Deferred Expense Capitalized Research And Development Costs
DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopmentCosts
63395000
CY2022Q4 sono Deferred Tax Assets Deferred Expense Capitalized Research And Development Costs
DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopmentCosts
9420000
CY2023Q3 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
17837000
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
8872000
CY2023Q3 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
15855000
CY2022Q4 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
14170000
CY2023Q3 sono Deferred Tax Assets Right Of Use Liability
DeferredTaxAssetsRightOfUseLiability
13097000
CY2022Q4 sono Deferred Tax Assets Right Of Use Liability
DeferredTaxAssetsRightOfUseLiability
7717000
CY2023Q3 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
7727000
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
9261000
CY2023Q3 us-gaap Deferred Tax Assets Operating Loss Carryforwards Foreign
DeferredTaxAssetsOperatingLossCarryforwardsForeign
7606000
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Foreign
DeferredTaxAssetsOperatingLossCarryforwardsForeign
7702000
CY2023Q3 sono Deferred Tax Assets Other Capitalized Costs
DeferredTaxAssetsOtherCapitalizedCosts
5364000
CY2022Q4 sono Deferred Tax Assets Other Capitalized Costs
DeferredTaxAssetsOtherCapitalizedCosts
3799000
CY2023Q3 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
2700000
CY2022Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
2239000
CY2023Q3 us-gaap Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
1852000
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
26363000
CY2023Q3 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
494000
CY2022Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
182000
CY2023Q3 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
211520000
CY2022Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
182212000
CY2023Q3 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
185840000
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
162267000
CY2023Q3 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
25680000
CY2022Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
19945000
CY2023Q3 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
22475000
CY2022Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
22125000
CY2023Q3 sono Deferred Tax Liabilities Right Of Use Asset
DeferredTaxLiabilitiesRightOfUseAsset
11392000
CY2022Q4 sono Deferred Tax Liabilities Right Of Use Asset
DeferredTaxLiabilitiesRightOfUseAsset
5940000
CY2022Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
14000
CY2023Q3 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
33867000
CY2022Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
28079000
CY2023Q3 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
8187000
CY2022Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
8134000
CY2023Q3 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
1659000
CY2022Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
1508000
CY2023Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
9846000
CY2022Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
9642000
CY2023Q3 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
8187000
CY2022Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
8134000
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
162267000
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
155978000
CY2020Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
113939000
CY2023 sono Valuation Allowance Deferred Tax Asset Increase Amount
ValuationAllowanceDeferredTaxAssetIncreaseAmount
23628000
CY2022 sono Valuation Allowance Deferred Tax Asset Increase Amount
ValuationAllowanceDeferredTaxAssetIncreaseAmount
13841000
CY2021 sono Valuation Allowance Deferred Tax Asset Increase Amount
ValuationAllowanceDeferredTaxAssetIncreaseAmount
49791000
CY2023 sono Valuation Allowance Deferred Tax Asset Decrease Amount
ValuationAllowanceDeferredTaxAssetDecreaseAmount
55000
CY2022 sono Valuation Allowance Deferred Tax Asset Decrease Amount
ValuationAllowanceDeferredTaxAssetDecreaseAmount
7552000
CY2021 sono Valuation Allowance Deferred Tax Asset Decrease Amount
ValuationAllowanceDeferredTaxAssetDecreaseAmount
7752000
CY2023Q3 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
185840000
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
162267000
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
155978000
CY2023 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-923000
CY2022 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
14433000
CY2021 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
32954000
CY2023 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-841000
CY2022 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-2594000
CY2021 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-9473000
CY2023 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
734000
CY2022 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
970000
CY2021 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
1430000
CY2023 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
104000
CY2022 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
-15532000
CY2021 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
-47496000
CY2023 us-gaap Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
7591000
CY2022 us-gaap Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
8983000
CY2021 us-gaap Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
21535000
CY2023 sono Effective Income Tax Rate Reconciliation Unrecognized Federal Tax Benefits
EffectiveIncomeTaxRateReconciliationUnrecognizedFederalTaxBenefits
184000
CY2022 sono Effective Income Tax Rate Reconciliation Unrecognized Federal Tax Benefits
EffectiveIncomeTaxRateReconciliationUnrecognizedFederalTaxBenefits
-2482000
CY2021 sono Effective Income Tax Rate Reconciliation Unrecognized Federal Tax Benefits
EffectiveIncomeTaxRateReconciliationUnrecognizedFederalTaxBenefits
4041000
CY2022 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
5013000
CY2021 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
-2681000
CY2023 us-gaap Effective Income Tax Rate Reconciliation Gilti Amount
EffectiveIncomeTaxRateReconciliationGiltiAmount
1234000
CY2022 us-gaap Effective Income Tax Rate Reconciliation Gilti Amount
EffectiveIncomeTaxRateReconciliationGiltiAmount
290000
CY2023 us-gaap Effective Income Tax Rate Reconciliation Fdii Amount
EffectiveIncomeTaxRateReconciliationFdiiAmount
6863000
CY2023 sono Effective Income Tax Rate Reconciliation Sub Part Income
EffectiveIncomeTaxRateReconciliationSubPartIncome
1374000
CY2023 sono Income Tax Reconciliation Section One Six Two M Executive Compensation Limitation
IncomeTaxReconciliationSectionOneSixTwoMExecutiveCompensationLimitation
2513000
CY2022 sono Income Tax Reconciliation Section One Six Two M Executive Compensation Limitation
IncomeTaxReconciliationSectionOneSixTwoMExecutiveCompensationLimitation
2574000
CY2023 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
-695000
CY2022 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
1079000
CY2021 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
-565000
CY2023 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
23592000
CY2022 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
6579000
CY2021 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
41655000
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
14668000
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1347000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1670000
CY2022Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
17021000
CY2021Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
21252000
CY2020Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
14721000
CY2023 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
566000
CY2022 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
6039000
CY2021 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
4000
CY2023 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
1164000
CY2022 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
1808000
CY2021 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
6535000
CY2023Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
17619000
CY2022Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
17021000
CY2021Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
21252000
CY2023Q3 us-gaap Undistributed Earnings Of Foreign Subsidiaries
UndistributedEarningsOfForeignSubsidiaries
6400000
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-10274000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
67383000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
158595000
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
127702885
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
127691030
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
122245212
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
127702885
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
137762078
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
140309152
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.08
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.53
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.3
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.08
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.49
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.13
CY2023 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
19342339
CY2022 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
12007847
CY2021 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
12590730
CY2023Q2 us-gaap Litigation Settlement Amount Awarded To Other Party
LitigationSettlementAmountAwardedToOtherParty
32500000
CY2023Q2 sono Royality Rate Per Infringing Units
RoyalityRatePerInfringingUnits
2.3
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
305147000
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
373356000
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
304173000
CY2022Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
672579000
CY2023Q3 us-gaap Gross Profit
GrossProfit
128054000
CY2023Q3 us-gaap Gross Profit
GrossProfit
171762000
CY2023Q2 us-gaap Gross Profit
GrossProfit
131618000
CY2022Q4 us-gaap Gross Profit
GrossProfit
285057000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-31239000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-23571000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-30652000
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
75188000
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.25
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.18
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.24
CY2022Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.59
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.25
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.18
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.24
CY2022Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.57
CY2022Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
316290000
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
371783000
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
399781000
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
664481000
CY2022Q4 us-gaap Gross Profit
GrossProfit
124099000
CY2022Q3 us-gaap Gross Profit
GrossProfit
175848000
CY2022Q2 us-gaap Gross Profit
GrossProfit
179034000
CY2022Q1 us-gaap Gross Profit
GrossProfit
317385000
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
-64067000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-597000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
8566000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
123481000
CY2022Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.5
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.07
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.97
CY2022Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.5
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.06
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.87
CY2023 us-gaap Restructuring And Related Cost Number Of Positions Eliminated Period Percent
RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent
0.07
CY2023Q3 us-gaap Restructuring Costs
RestructuringCosts
11400000
CY2023Q1 sono Non Recurring Write Offs Operating Lease Right Of Use Assets And Accelerated Depreciation Leasehold Improvements
NonRecurringWriteOffsOperatingLeaseRightOfUseAssetsAndAcceleratedDepreciationLeaseholdImprovements
4800000
CY2023 us-gaap Severance Costs1
SeveranceCosts1
9083000
CY2023 sono Lease Abandonment Charges
LeaseAbandonmentCharges
5600000
CY2023 us-gaap Other Restructuring Costs
OtherRestructuringCosts
966000
CY2023 us-gaap Restructuring Costs And Asset Impairment Charges
RestructuringCostsAndAssetImpairmentCharges
15649000
CY2023 sono Non Recurring Write Offs Operating Lease Right Of Use Assets And Accelerated Depreciation Leasehold Improvements
NonRecurringWriteOffsOperatingLeaseRightOfUseAssetsAndAcceleratedDepreciationLeaseholdImprovements
4800000
CY2023 us-gaap Restructuring Costs And Asset Impairment Charges
RestructuringCostsAndAssetImpairmentCharges
15649000
CY2023Q3 us-gaap Restructuring Charges
RestructuringCharges
10105000
CY2023Q3 us-gaap Payments For Restructuring
PaymentsForRestructuring
7981000
CY2023Q3 us-gaap Restructuring Reserve
RestructuringReserve
2124000
CY2023 ecd Trd Arr Adoption Date
TrdArrAdoptionDate
September 7, 2023
CY2023 ecd Trd Arr Ind Name
TrdArrIndName
Julius Genachowski
CY2023 ecd Trd Arr Ind Title
TrdArrIndTitle
Chairperson and a member of our Board of Directors
CY2023 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
true
CY2023Q3 ecd Trd Arr Securities Agg Avail Amt
TrdArrSecuritiesAggAvailAmt
46434

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
0000950170-23-065135-index-headers.html Edgar Link pending
0000950170-23-065135-index.html Edgar Link pending
0000950170-23-065135.txt Edgar Link pending
0000950170-23-065135-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
img15472946_0.jpg Edgar Link pending
img241470037_0.jpg Edgar Link pending
img249328750_0.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
sono-20230930.htm Edgar Link pending
sono-20230930.xsd Edgar Link pending
sono-ex10_13.htm Edgar Link pending
sono-ex10_8.htm Edgar Link pending
sono-ex23_1.htm Edgar Link pending
sono-ex31_1.htm Edgar Link pending
sono-ex31_2.htm Edgar Link pending
sono-ex32_1.htm Edgar Link pending
sono-ex32_2.htm Edgar Link pending
sono-ex97.htm Edgar Link pending
sono-20230930_lab.xml Edgar Link unprocessable
sono-20230930_def.xml Edgar Link unprocessable
sono-20230930_cal.xml Edgar Link unprocessable
sono-20230930_pre.xml Edgar Link unprocessable
sono-20230930_htm.xml Edgar Link completed